Mercer Global Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90.3K Buy
11,418
+6,420
+128% +$104K ﹤0.01% 3040
2025
Q4
$86.1K Buy
+4,998
New +$96.9K ﹤0.01% 2737

Other funds holding AGL

Mercer Global Advisors's AGL Position: Q1 2026 in Review

Mercer Global Advisors increased its Agilon Health (AGL) stake by 128% in Q1 2026, buying an estimated $104K and bringing the position to 11,418 shares worth $90.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Mercer Global Advisors first reported a position in AGL in Q4 2025 and has held it in 2 quarters since. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Mercer Global Advisors held 11,418 shares of Agilon Health worth $90.3K as of Q1 2026.
  • Mercer Global Advisors bought 6,420 Agilon Health shares in Q1 2026, an estimated $104K.
  • Agilon Health made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3040 holding.
  • Mercer Global Advisors first reported a position in Agilon Health in Q4 2025 and has held it in 2 quarters since.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.